KAPPAPROCT Trademark of InDex Pharmaceuticals AB - Serial Number 79002111

KAPPAPROCT Trademark

Trademark Overview

On Monday, March 29, 2004, a trademark application was filed for KAPPAPROCT with the United States Patent and Trademark Office. The USPTO has given the KAPPAPROCT trademark a serial number of 79002111. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, March 29, 2024. This trademark is owned by InDex Pharmaceuticals AB. The KAPPAPROCT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for human purposes, namely pharmaceutical preparations for treating inflammatory diseases, cancer and sepsis

General Information

Serial Number	79002111
Word Mark	KAPPAPROCT
Filing Date	Monday, March 29, 2004
Status	404 - IR CANCELLED - US REGISTRATION CANCELLED
Status Date	Friday, March 29, 2024
Registration Number	3090431
Registration Date	Tuesday, May 9, 2006
Mark Drawing	4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition Date	Tuesday, February 14, 2006

Trademark Statements

Goods and Services

Pharmaceuticals for human purposes, namely pharmaceutical preparations for treating inflammatory diseases, cancer and sepsis

Classification Information

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	F - NOT AVAILABLE
Class Status Date	Friday, April 5, 2013
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

Party Name	InDex Pharmaceuticals AB
Party Type	30 - Original Registrant
Legal Entity Type	09 - Joint Stock Company
Address	SE-171 77 Stockholm SE

Party Name	InDex Pharmaceuticals AB
Party Type	20 - Owner at Publication
Legal Entity Type	09 - Joint Stock Company
Address	SE-171 77 Stockholm SE

Party Name	InDex Pharmaceuticals AB
Party Type	10 - Original Applicant
Legal Entity Type	09 - Joint Stock Company
Address	SE-171 77 Stockholm SE

Trademark Events

Event Date	Event Description
Tuesday, May 3, 2005	APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 13, 2004	SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, May 17, 2004	NEW APPLICATION ENTERED
Thursday, October 14, 2004	ASSIGNED TO EXAMINER
Thursday, October 14, 2004	NON-FINAL ACTION WRITTEN
Tuesday, October 19, 2004	NON-FINAL ACTION MAILED
Thursday, November 18, 2004	REFUSAL PROCESSED BY IB
Thursday, April 21, 2005	PAPER RECEIVED
Thursday, April 21, 2005	CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 3, 2005	AMENDMENT FROM APPLICANT ENTERED
Tuesday, May 24, 2005	FINAL REFUSAL MAILED
Friday, December 16, 2005	ASSIGNED TO LIE
Tuesday, May 24, 2005	FINAL REFUSAL WRITTEN
Thursday, October 13, 2005	NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, October 13, 2005	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, November 4, 2005	NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, November 23, 2005	PAPER RECEIVED
Wednesday, November 23, 2005	CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 8, 2005	AMENDMENT FROM APPLICANT ENTERED
Friday, December 9, 2005	APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 5, 2013	CANCELLED SECTION 71
Tuesday, January 3, 2006	LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 25, 2006	NOTICE OF PUBLICATION
Tuesday, February 14, 2006	PUBLISHED FOR OPPOSITION
Tuesday, May 9, 2006	REGISTERED-PRINCIPAL REGISTER
Monday, November 20, 2006	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, December 18, 2006	FINAL DISPOSITION PROCESSED
Monday, December 18, 2006	FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 30, 2007	FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, January 16, 2012	TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 30, 2024	DEATH OF INTERNATIONAL REGISTRATION
Friday, May 11, 2018	NEW REPRESENTATIVE AT IB RECEIVED
Sunday, June 30, 2013	NOTIFICATION PROCESSED BY IB
Thursday, December 5, 2013	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, April 17, 2014	INTERNATIONAL REGISTRATION RENEWED
Saturday, June 14, 2014	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, March 6, 2015	TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

kappaproct inflammatory diseases cancer sepsis treating preparations human purposes namely pharmaceutical